Gut indigenous microbiota and epigenetics
This review introduces and discusses data regarding fundamental and applied investigations in mammalian epigenomics and gut microbiota received over the last 10 years. Analysis of these data enabled the author first to come to the conclusion that the multiple low molecular weight substances of indig...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2012-03-01
|
Series: | Microbial Ecology in Health and Disease |
Subjects: | |
Online Access: | http://www.microbecolhealthdis.net/index.php/mehd/article/view/17195/21264 |
id |
doaj-1c8925eff4ca49069fe0c013991269cc |
---|---|
record_format |
Article |
spelling |
doaj-1c8925eff4ca49069fe0c013991269cc2020-11-24T22:00:31ZengTaylor & Francis GroupMicrobial Ecology in Health and Disease0891-060X1651-22352012-03-012301610.3402/mehd.v23i0.17195Gut indigenous microbiota and epigeneticsBoris Arkadievich ShenderovThis review introduces and discusses data regarding fundamental and applied investigations in mammalian epigenomics and gut microbiota received over the last 10 years. Analysis of these data enabled the author first to come to the conclusion that the multiple low molecular weight substances of indigenous gut microbiota origin should be considered one of the main endogenous factors actively participating in epigenomic mechanisms that responsible for the mammalian genome reprogramming and post-translated modifications. Gut microecological imbalance coursed by various biogenic and abiogenic agents and factors can produce the different epigenetic abnormalities and the onset and progression of metabolic diseases associated. The author substantiates the necessity to create an international project ‘Human Gut Microbiota and Epigenomics’ that facilitates interdisciplinary collaborations among scientists and clinicians engaged in host microbial ecology, nutrition, metagenomics, epigenomics and metabolomics investigations as well as in diseases prevention and treatment. Some priority scientific and applied directions in the current omic technologies coupled with gnotobiological approaches are suggested that can open a new era in characterizing the role of the symbiotic microbiota small metabolic and signal molecules in the host epigenomics. Although discussed subject is only at an early stage its validation can open novel approaches in drug discovery studies.http://www.microbecolhealthdis.net/index.php/mehd/article/view/17195/21264gut microfloramicrobial small moleculesmammalian epigenomics |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Boris Arkadievich Shenderov |
spellingShingle |
Boris Arkadievich Shenderov Gut indigenous microbiota and epigenetics Microbial Ecology in Health and Disease gut microflora microbial small molecules mammalian epigenomics |
author_facet |
Boris Arkadievich Shenderov |
author_sort |
Boris Arkadievich Shenderov |
title |
Gut indigenous microbiota and epigenetics |
title_short |
Gut indigenous microbiota and epigenetics |
title_full |
Gut indigenous microbiota and epigenetics |
title_fullStr |
Gut indigenous microbiota and epigenetics |
title_full_unstemmed |
Gut indigenous microbiota and epigenetics |
title_sort |
gut indigenous microbiota and epigenetics |
publisher |
Taylor & Francis Group |
series |
Microbial Ecology in Health and Disease |
issn |
0891-060X 1651-2235 |
publishDate |
2012-03-01 |
description |
This review introduces and discusses data regarding fundamental and applied investigations in mammalian epigenomics and gut microbiota received over the last 10 years. Analysis of these data enabled the author first to come to the conclusion that the multiple low molecular weight substances of indigenous gut microbiota origin should be considered one of the main endogenous factors actively participating in epigenomic mechanisms that responsible for the mammalian genome reprogramming and post-translated modifications. Gut microecological imbalance coursed by various biogenic and abiogenic agents and factors can produce the different epigenetic abnormalities and the onset and progression of metabolic diseases associated. The author substantiates the necessity to create an international project ‘Human Gut Microbiota and Epigenomics’ that facilitates interdisciplinary collaborations among scientists and clinicians engaged in host microbial ecology, nutrition, metagenomics, epigenomics and metabolomics investigations as well as in diseases prevention and treatment. Some priority scientific and applied directions in the current omic technologies coupled with gnotobiological approaches are suggested that can open a new era in characterizing the role of the symbiotic microbiota small metabolic and signal molecules in the host epigenomics. Although discussed subject is only at an early stage its validation can open novel approaches in drug discovery studies. |
topic |
gut microflora microbial small molecules mammalian epigenomics |
url |
http://www.microbecolhealthdis.net/index.php/mehd/article/view/17195/21264 |
work_keys_str_mv |
AT borisarkadievichshenderov gutindigenousmicrobiotaandepigenetics |
_version_ |
1725844086843244544 |